{"url":"https://lda.senate.gov/api/v1/filings/68ccf011-b596-43f5-a67a-bf987bf55bec/","filing_uuid":"68ccf011-b596-43f5-a67a-bf987bf55bec","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2024,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/68ccf011-b596-43f5-a67a-bf987bf55bec/print/","filing_document_content_type":"text/html","income":"9500.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jennifer Leib","dt_posted":"2024-07-17T10:08:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1032 15th Street NW","registrant_address_2":"Suite 252","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401105127,"url":"https://lda.senate.gov/api/v1/registrants/401105127/","house_registrant_id":null,"name":"IPOLICY SOLUTIONS","description":"Government Affairs Consulting firm","address_1":"1032 15th Street NW","address_2":"Suite 252","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIFER LEIB","contact_telephone":"+1 301-613-6081","dt_updated":"2026-07-16T11:52:07.892579-04:00"},"client":{"id":60206,"url":"https://lda.senate.gov/api/v1/clients/60206/","client_id":60206,"name":"PIKE THERAPEUTICS","general_description":"Pharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"BC","state_display":"British Columbia","country":"CA","country_display":"Canada","ppb_state":"BC","ppb_state_display":"British Columbia","ppb_country":"CA","ppb_country_display":"Canada","effective_date":"2024-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S4226 Cannabis Administration and Opportunity Act Parkinson's disease treatment","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71001,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":"RACHEL","last_name":"LEIB","suffix":null,"suffix_display":null},"covered_position":"Fellow, Senate Committee on Health, Education, Labor, and Pensions","new":false},{"lobbyist":{"id":71064,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"ANDERSON BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140924,"prefix":null,"prefix_display":null,"first_name":"LINDSEY","nickname":null,"middle_name":null,"last_name":"TRISCHLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}